Comparing the effectiveness of three pain relief methods for inserting a needle into the implanted venous access chemoport: A randomized controlled trial

Shin, Jinhee; Kim, Gwang Suk; Sim, Hyebeen

doi:10.1111/ijn.12974

Cited by 7 publications

(6 citation statements)

References 34 publications

(38 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In this parallel randomized controlled trial, the intervention group was subjected to lidocaine spray treatment, while the control group was a blank control, and the pain score was the primary outcome indicator. According to previous literature [ 10 ], the pain caused by non-coring needle puncture at the TIVAP was 3.91 ± 1.35 in the control group and 1.57 ± 0.68 in the lidocaine cream intervention group. Setting α=0.05 (bilateral) and β=0.10, the sample size in the intervention group and the control group was calculated as N1=N2=5 using the PASS11 software.…”

Section: Methodsmentioning

confidence: 92%

“…The infusion or maintenance period after port placement requires puncture with a non-coring needle, but patients often complain of significant pain during the puncture as the structure of the non-coring needle slows down its speed through the skin [ 8 ]. It is reported that the incidence of mild and moderate to severe pain caused by TIVAP needle insertion is 67.5% and 34.9%, respectively [ 9 ], and the pain score can reach 3.91 ± 1.35 [ 10 ]. The pain caused by needle puncture is related to the fear and suffering of patients [ 11 ].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Effect of lidocaine spray on relieving non-coring needle puncture-related pain in patients with totally implantable venous access port: a randomized controlled trial

Zhu

Zhang

et al. 2023

Support Care Cancer

View full text Add to dashboard Cite

Purpose Patients with the placement of a totally implantable venous access port (TIVAP) commonly suffer from pain caused by inserting a non-coring needle. At present, lidocaine cream and cold spray are extensively used for pain management, but they are complex to manage in busy medical environments and developing countries. The lidocaine spray combines the analgesic effect of lidocaine cream and the rapid onset of cold spray, which can effectively alleviate the pain related to non-coring needle puncture in patients with TIVAP. This randomized-controlled trial aimed to explore the effectiveness, acceptability, and safety of lidocaine spray in relieving the pain of non-coring needle puncture in patients with TIVAP. Methods A total of 84 patients who were hospitalized in the oncology department of a Grade III Level-A hospital in Shanghai from January 2023 to March 2023 and were implanted with TIVAP and required non-coring needle puncture were selected as the study subjects. The recruited patients were randomly assigned to the intervention group and the control group (n=42). Before routine maintenance, the intervention group received lidocaine spray 5 min before disinfection, while the control group received water spray 5 min before disinfection. The main clinical outcome was pain, and the degree of puncture pain in both groups was evaluated using the visual analogue scale. Results There were no significant differences between the two groups in age, gender, educational level, body mass index, port implantation time, and disease diagnosis (P>0.05). The pain score in the intervention and control groups was 15.12±6.61mm and 36.50±18.79mm, respectively (P<0.001). There were 2 (4.8%) patients with moderate pain in the intervention group and 18 (42.9%) patients with moderate pain in the control group (P<0.001). In the control group, 3 (7.1%) patients reported severe pain. The median comfortability score for the two groups of patients was 10, but there was a difference between the two groups (P<0.05) because the intervention group tilted to the right. The successful puncture rate of the first time puncture had no difference between the two groups, both being 100%. Moreover, 33 patients (78.6%) in the intervention group and 12 patients (28.6%) in the control group reported that they would choose the same spray for intervention in the future (P<0.001). During the 1 week of follow-up, 1 patient in the intervention group developed skin itching (P>0.05). Conclusions The local use of lidocaine spray in patients with TIVAP is effective, acceptable, and safe to alleviate the pain caused by non-coring needle puncture. Trial registration Chinese Clinical Trial Registry (registration number: ChiCTR2300072976)

show abstract

Section: Methodsmentioning

confidence: 92%

Section: Introductionmentioning

confidence: 99%

Effect of lidocaine spray on relieving non-coring needle puncture-related pain in patients with totally implantable venous access port: a randomized controlled trial

Zhu

Zhang

et al. 2023

Support Care Cancer

View full text Add to dashboard Cite

show abstract

“…The quality of pain management depends on the nurse's knowledge, attitude, and skill regarding painful interventions (Savcı et al, 2022). The American Society for Pain Management Nursing endorses pain control before and during painful procedures (Shin et al, 2022). Also, immunization guidelines suggest that site pain should be prevented, and therefore inexpensive interventions which are easy to implement need to be available (Redfern et al, 2019).…”

Section: Discussionmentioning

confidence: 99%

A comparison of the effect on pain management of two non‐pharmacological methods used during administration of Pfizer–BioNTech COVID‐19 vaccine (BNT162b2): A randomized controlled study

Yılmaz

Kutlu

Baki

2023

Japan Journal Nursing Sci

View full text Add to dashboard Cite

Aims This study was conducted with the aim of examining the effect on pain intensity of the vibration technique applied at the injection site and squeezing a stress ball during the administration of Pfizer–BioNTech COVID‐19 vaccination. Methods This was a randomized controlled single‐blind experimental study. The study included 120 adults who were randomly selected between July and November 2022. One experimental group (n = 40) received local vibration by means of a Buzzy® device, and the other (n = 40) were given a stress ball to squeeze. Routine vaccination procedure was performed with the control group (n = 40). The level of pain felt during the vaccination procedure was assessed on a visual analog scale. Results The pain score of individuals during the vaccination procedure was found to be significantly lower in the vibration group than in the control group (P = .005) and the stress ball group (P = .036), but there was no significant difference between the control and stress ball groups (P = .851). Also, it was found that the variables of gender, age and body mass index did not affect the average pain intensity of individuals during the vaccination procedure. Conclusions It was found that local vibration applied by means of the Buzzy® device was effective in reducing the levels of pain relating to administration of the Pfizer–BioNTech COVID‐19 vaccination. Nurses should think of the application of vibration as a choice in the management of pain relating to Pfizer–BioNTech COVID‐19 vaccination.

show abstract

“…They discovered that the 2.5% lidocaine had no impact in reducing the discomfort brought on by hemodialysis needle insertion [27]. Additionally, a study comparing the efficiency of lidocaine cream and cryotherapy for putting a needle into the implanted venous access chemotherapy port revealed that lidocaine cream had the strongest effect, followed by cryotherapy, and that both lower pain levels than the control group [42].…”

Section: Discussionmentioning

confidence: 99%

The effect of cold packs, lidocaine spray, and flashlights on cannulation pain in patients undergoing hemodialysis: a randomized controlled trial

Gouda,

EL said,

Fahmy

2023

Futur J Pharm Sci

View full text Add to dashboard Cite

Background Pain is a frequent and critical problem in daily hemodialysis practice. The pain experienced during arteriovenous fistula cannulation varies from 12% to even 80% in hemodialysis patients depending on the pain assessment tools used. Pain can lead to sleep problems, decreased compliance with hemodialysis therapy, frequent hospital hospitalizations, a decline in quality of life, and high death rates. Despite utilizing several methods as pain relief, it is still unknown in the literature and practice which method is the most effective. The purpose of the study was to compare the effect of lidocaine spray, cold packs, and flashlights on the pain induced by arteriovenous cannulation in hemodialysis patients. This was a prospective randomized open-label controlled trial. Hundred and eight adult patients on regular hemodialysis were recruited and simply randomized into one of four groups (lidocaine spray, cold packs, flashlights, and control) before cannulation. Results The mean pain severity using visual analog scale was 4.3 (3.3–5.7) in lidocaine group, 4 (3–5.7) in cold packs group, 4.3 (3.3–5.3) in flashlight group, and 4.7 (3–6) in control group. There was a borderline significant difference between groups using Kruskal–Wallis test (p = 0.054). The post hoc Tukey test showed that only cold packs differ from control group with borderline significance (p = 0.051). Conclusion The results showed that cold packs were safe and effective than lidocaine spray or flashlights in reducing cannulation pain. It is suggested to implement this method before cannulation in hemodialysis patients to reduce pain and improve quality of life. Future studies are needed to compare different application times of cold packs and its impact on pain scores to recommend the optimum time needed to achieve maximum analgesic effect. Trail registration: Clinical trials.gov NCT05822063, REC #194. Graphical abstract

show abstract

Comparing the effectiveness of three pain relief methods for inserting a needle into the implanted venous access chemoport: A randomized controlled trial

Cited by 7 publications

References 34 publications

Effect of lidocaine spray on relieving non-coring needle puncture-related pain in patients with totally implantable venous access port: a randomized controlled trial

Effect of lidocaine spray on relieving non-coring needle puncture-related pain in patients with totally implantable venous access port: a randomized controlled trial

A comparison of the effect on pain management of two non‐pharmacological methods used during administration of Pfizer–BioNTech COVID‐19 vaccine (BNT162b2): A randomized controlled study

The effect of cold packs, lidocaine spray, and flashlights on cannulation pain in patients undergoing hemodialysis: a randomized controlled trial

Contact Info

Product

Resources

About